Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive Impairment
Shorena Janelidze(Lund University), Oskar Hansson(Eli Lilly (United States)), Erik Stomrud(Lund University), Kaj Blennow(Sahlgrenska University Hospital), Yingxin He(Washington University in St. Louis), Vitaliy Ovod(Washington University in St. Louis), Joel B. Braunstein(C2N Diagnostics (United States)), Niklas Mattsson(Malmö University), Gemma Salvadó(Lund University), Cyrus A. Raji(Washington University in St. Louis), Nicolas R. Barthélemy(Washington University in St. Louis), David M. Holtzman(Hope Center for Neurological Disorders), Yan Li(Shanxi Medical University), Nicholas J. Ashton(King's College London), Suzanne E. Schindler(Washington University in St. Louis), James G. Bollinger(Washington University in St. Louis), Randall J. Bateman(Washington University in St. Louis), John C. Morris(Washington University in St. Louis), Sebastian Palmqvist(Skåne University Hospital)
Cited by 109
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
Alzheimer disease
|Nature Reviews Disease Primers|2021|2.4k